[Pharmacological and clinical aspects of fluvoxamine (Depromel), the first selective serotonin reuptake inhibitor approved for clinical use employed in Japan]. [electronic resource]
Producer: 20000807Description: 271-9 p. digitalISSN:- 0015-5691
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.